Preparation and Characterization of Gastroretentive Floating Microspheres of Ofloxacin Hydrochloride
DOI:
https://doi.org/10.37285/ijpsn.2010.3.1.4Abstract
As Ofloxacin is preferably absorbed from the upper part of the gastrointestinal tract and is readily soluble in the acidic environment of the stomach, the floating microspheres of ofloxacin were formulated to develop gastroretentive formulation. These floating microspheres release the drug in the stomach and upper gastrointestinal tract and thereby improve the bioavailability. In the present study, six formulations of ofloxacin hydrochloride were prepared as floating microspheres by solvent diffusion technique using polymers such as ethyl cellulose, polyvinyl pyrrolidone K-90 and poly vinyl alcohol in different ratios. The prepared microspheres were evaluated for different physicochemical tests such as particle size, percent drug entrapment, drug content uniformity, SEM, buoyancy test, and in vitro drug release studies. The results of all the physicochemical tests of all formulations were found to be satisfactory. In vitro floatability studies revealed that most of the microspheres (52.5% to 95.5%) were floatable. The in vitro drug release was found to be in the range of 39.64 to 93.64 % at the end of 6 hours. It is concluded that these floating microspheres can be selected for the development of gastroretentive drug delivery system of ofloxacin hydrochloride for potential therapeutic uses.
Downloads
Metrics
Keywords:
Gastroretentive Floating Microspheres, Ofloxacin hydrochloride
Downloads
Published
How to Cite
Issue
Section
References
rora S, Ali J, Ahuja A, Khar RK, Baboota S, Floating drug delivery systems: A review. AAPS PharmSciTech 6(3): article 47 (2005).
Bardonnet PL, Faivre V, Pugh WJ, Piffaretti JC, Falson F. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J. Control. Release 111: 1-18 (2006).
Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102: 720–727 (1992).
Chavanpatil M, Jain P, Chaudhari S, Shear R, Vavia P. Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation. Int. J. Pharm. 304: 178–184 (2005).
Eytan AK, Eran L, Miklos B, Eva C, Michael F, Amnon H. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on levodopa absorption in humans. Pharm. Res. 20: 1466-73 (2003).
Hwang SJ, Park H, Park K, Gastric retentive drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 15: 243–284 (1998).
Kale R, Rao BS, Sharma S, Ramanmurthy KV. Preparation and evaluation of floatable drug delivery system of ketorolac tromethamine. Int. J. Pharm. Excp. 32: 64-65 (2001).
Kawashima Y, Niwa T, Takeuchi H, Hino T, Ito Y. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J. Controll. Release. 16; 279-290 (1991).
Lee J-H, Park TG, Choi H-K. Development of oral drug delivery system using foating microspheres. J Microencapsulation. 16: 715-29 (1999).
Semalty A, Semalty M. Preparation and characterization of mucoadhesive microspheres of ciprofloxacin hydrochloride. Indian Drugs. 44: 368-72 (2007).
Semalty M, Semalty A. Gastroretentive floating microspheres of diltiazem hydrochloride, Pharma Buzz. 3(12): 24-28 (2008).
Sen H, Kshirsagar RS. Pharmaceutical composition for a controlled release of active ingredient. (2002) WO024187.
Soppimath KS, Kulkarni AR, Aminabhavi TM. Development of hollow microspheres as floating controlled release system for cardiovascular drugs. Drug Dev. Ind. Pharm. 27(6):507-15 (2001).
Streubel A, Siepmann J, Bodmeier R. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci. 18: 37–45 (2003).
Swarbrick J, Martin A. Physical Pharmacy. Waverly(pvt) Ltd. New Delhi 4thEd. 1996; 423-25.
